Comment on “Review of Donanemab and Lecanemab in Mild Dementia Stage of Alzheimer’s Disease: Progress and Challenges”
The Senior Care Pharmacist · 01.08.2026 · 41 (5) · 157-158
DOI: 10.4140/tcp.n.2026.157 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Senior Care Pharmacist, erschienen am 01.08.2026. Verfasst von Marketa Marvanova. Beteiligte Einrichtung: Dean and Professor, Pacific University School of Pharmacy. Die Arbeit nennt 8 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Dean and Professor, Pacific University School of Pharmacy.
Zitieren
APA
Marvanova, M. (2026). Comment on “Review of Donanemab and Lecanemab in Mild Dementia Stage of Alzheimer’s Disease: Progress and Challenges”. The Senior Care Pharmacist, 41(5), 157-158. https://doi.org/10.4140/tcp.n.2026.157
Vancouver
Marvanova M. Comment on “Review of Donanemab and Lecanemab in Mild Dementia Stage of Alzheimer’s Disease: Progress and Challenges”. The Senior Care Pharmacist. 2026;41(5):157-158. doi:10.4140/tcp.n.2026.157
BibTeX
@article{Marvanova2026,
author = {Marvanova, Marketa},
title = {Comment on “Review of Donanemab and Lecanemab in Mild Dementia Stage of Alzheimer’s Disease: Progress and Challenges”},
journal = {The Senior Care Pharmacist},
year = {2026},
volume = {41},
number = {5},
pages = {157--158},
doi = {10.4140/tcp.n.2026.157}
}
EUVIMED